Individuals with IBD do not seem to incur an intrinsic risk of developing lymphoma. However, there is evidence to suggest that either alone or in combination with anti-TNF, the use of thiopurines ...

Direct costs associated with IBD include ambulatory visits to gastroenterologists, emergency department visits, admissions ...

Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment ...

Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

Its AI-led platform aims to turn biological disease models into actionable ... Globally, more than six million people are affected by IBD, which presents as Crohn’s disease or ulcerative colitis ...

The primary endpoint was clinical remission at week 12, with secondary endpoints of clinical response and endoscopic ...

Prademagene zamikeracel (pz-cel) could be a new treatment for rare genetic disease recessive dystrophic epidermolysis bullosa (RDEB).

IBD is a lifelong disease that currently has ... Rise is focused on developing immunological-based biological medicines using a unique and proprietary oral biologics delivery platform.

SAN FRANCISCO and SUZHOU, China, Oct. 16, 2024 /PRNewswire/ -- Innovent Biologics ... subjects with moderately to severely active ulcerative colitis (UC). This study aims to evaluate the efficacy ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious ...

We truly hope to bring accessible and high-quality innovative biologics to benefit a wide range of patients." About Ulcerative Colitis Ulcerative colitis is a chronic inflammatory disease ...